PPBT Stock Analysis: Buy, Sell, or Hold?
PPBT - Purple Biotech Ltd. American Depositary Shares
$1.58
0.04 (2.60%)
▲
5d:
-46.8%
30d:
-59.98%
90d:
-61.46%
WAIT
LOW Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 20, 2026
0d
Get Alerted When PPBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PPBT is down 46.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PPBT is down 46.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PPBT is currently trading at $1.58, which is considered oversold relative to its 30-day fair value range of $2.70 to $3.94.
Technical Outlook: Technically, PPBT is in a strong uptrend. The price is currently testing key support at $2.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+1798.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PPBT is in a strong uptrend. The price is currently testing key support at $2.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+1798.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.70 -
$3.94
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading 1798.7% below Wall St target ($30.00)
- WARNING: Recommendation downgraded due to -46.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.70 -
$3.94
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.70
Resistance Level
$3.09
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.80
Wall Street Target
$30.00
(+1798.7%)
Share & Embed Analysis
Last updated: June 13, 2026 8:51 AM ET
Data refreshes hourly during market hours. Next update: 9:51 AM
Data refreshes hourly during market hours. Next update: 9:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PPBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1023 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$82 | 48 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 61 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 51 HOLD |
